Dicpinigaitis PV (2022) LUNG year in review: 2021. Lung 200(1):1–4

Google Scholar 

O’Driscoll JM et al (2022) Undiagnosed chronic obstructive pulmonary disease is highly prevalent in patients referred for dobutamine stress echocardiography with shortness of breath. Lung 200(1):41–48

Google Scholar 

Rahman HH, Niemann D, Munson-McGee SH (2022) Urinary metals, arsenic, and polycyclic aromatic hydrocarbon exposure and risk of self-reported emphysema in the US adult population. Lung 200(2):237–249

CAS  Google Scholar 

Cao P et al (2022) Serum 8-hydroxy-2’-deoxyguanosine predicts severity and prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease. Lung 200(1):31–39

CAS  Google Scholar 

Chen Z et al (2022) Serum creatinine/cystatin C ratio as a predictor of in-hospital mortality in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. Lung 200(5):609–617

CAS  Google Scholar 

Golpe R et al (2022) Trajectories of severe exacerbations of chronic obstructive pulmonary disease and their relationship with mortality risk. Lung 200(5):601–607

Google Scholar 

Ben Anes A et al (2022) Plasma lipid profiling identifies phosphatidylcholine 34:3 and triglyceride 52:3 as potential markers associated with disease severity and oxidative status in chronic obstructive pulmonary disease. Lung 200(4):495–503

CAS  Google Scholar 

Kendra M et al (2022) Decreasing hospital readmissions utilizing an evidence-based COPD care bundle. Lung 200(4):481–486

Google Scholar 

De Nuccio F, Piscitelli P, Toraldo DM (2022) Gut-lung microbiota interactions in chronic obstructive pulmonary disease (COPD): potential mechanisms driving progression to COPD and epidemiological data. Lung 200(6):773–781

Google Scholar 

Pini L et al (2022) Acute effect of bronchodilator on intrathoracic airway wall compliance in COPD patients. Lung 200(4):473–480

CAS  Google Scholar 

Sillen MJH et al (2022) Effects of pulmonary rehabilitation including inspiratory muscle training in patients with chronic obstructive pulmonary disease after stratification by the degree of static hyperinflation. Lung 200(4):487–494

Google Scholar 

Mei X et al (2022) Poly I: C exacerbates airway inflammation and remodeling in cigarette smoke-exposed mice. Lung 200(6):677–686

CAS  Google Scholar 

Garantziotis S (2022) Adding (viral) insult to (smoke) injury may prolong COPD changes after smoking cessation (editorial). Lung 200(6):671–672

Google Scholar 

Rizzo JA et al (2022) Ventilation rates achieved in eucapnic voluntary hyperpnea challenge and exercise-induced bronchoconstriction diagnosis in young patients with asthma. Lung 200(2):229–236

Google Scholar 

Chan R, Lipworth B (2022) Forced vital capacity and low frequency reactance area measurements are associated with asthma control and exacerbations. Lung 200(3):301–303

CAS  Google Scholar 

Fang XM et al (2022) Endogenous adenosine 5’-monophosphate, but not acetylcholine or histamine, is associated with asthma control, quality of life, and exacerbations. Lung 200(5):579–589

CAS  Google Scholar 

Chanachon PN et al (2022) Association of dyslipidemia and respiratory resistance assessed by the forced oscillation technique in asthmatic children. Lung 200(1):73–82

CAS  Google Scholar 

Pham DD et al (2022) Different impacts of blood and sputum eosinophil counts on lung function and clinical outcomes in asthma: findings from the COREA cohort. Lung 200(6):697–706

Google Scholar 

Chan R, Lipworth BJ (2022) Impact of biologic therapy on the small airways asthma phenotype. Lung 200(6):691–696

CAS  Google Scholar 

Alachraf K et al (2022) Social determinants of emergency department visits in mild compared to moderate and severe asthma. Lung 200(2):221–226

Google Scholar 

Holmes J, Heaney LG, McGarvey LPA (2022) Objective and subjective measurement of cough in asthma: a systematic review of the literature. Lung 200(2):169–178

Google Scholar 

Diab N et al (2022) Narrative review of the mechanisms and treatment of cough in asthma, cough variant asthma, and non-asthmatic eosinophilic bronchitis. Lung 200(6):707–717

Google Scholar 

Chiba Y et al (2022) Hyperresponsiveness to extracellular acidification-mediated contraction in isolated bronchial smooth muscles of murine experimental asthma. Lung 200(5):591–599

CAS  Google Scholar 

Castellani C, Castellani H, Benn BS (2022) Transbronchial lung cryobiopsy is safe and effective for diagnosing acutely ill hospitalized patients with new diffuse parenchymal lung disease. Lung 200(2):153–159

Google Scholar 

Low S-W, Maldonado F (2022) Cryobiopsies for diffuse parenchymal lung disease in acutely ill patients: just because we can does not mean we should (editorial). Lung 200(2):149–151

Google Scholar 

Walscher J et al (2022) Comparison of a 22G crown-cut needle with a conventional 22G needle with EBUS guidance in diagnosis of sarcoidosis. Lung 200(5):633–641

CAS  Google Scholar 

Torii A et al (2022) EUS-B-FNA enhances the diagnostic yield of EBUS bronchoscope for intrathoracic lesions. Lung 200(5):643–648

Google Scholar 

Martin-Deleon R et al (2022) EBUS-TBNA in extrathoracic malignancies: diagnostic and prognostic implications. Lung 200(6):747–753

Google Scholar 

Oberg CL et al (2022) Novel robotic-assisted cryobiopsy for peripheral pulmonary lesions. Lung 200(6):737–745

Google Scholar 

Styrvoky K et al (2022) Shape-sensing robotic-assisted bronchoscopy with concurrent use of radial endobronchial ultrasound and cone beam computed tomography in the evaluation of pulmonary lesions. Lung 200(6):755–761

Google Scholar 

Nakashima K et al (2022) Sulfated glycans recognized by S1 monoclonal antibody can serve as a diagnostic marker for malignant pleural mesothelioma. Lung 200(3):339–346

CAS  Google Scholar 

Zhang GH, Liu YJ, Ji MD (2022) Risk factors, prognosis, and a new nomogram for predicting cnacer-specific survival among lung cancer patinets with brain metastasis: a retrospective study based on SEER. Lung 200(1):83–93

Google Scholar 

Wang T, Zhu X, Wang K (2022) CircMIIP contributes to non-small cell lung cancer progression by binding miR-766-5p to upregulate FAM83A expression. Lung 200(1):107–117

CAS  Google Scholar 

Detopoulou P, Voulgaridou G, Papadopoulou S (2022) Cancer, phase angle and sarcopenia: the role of diet in connection with lung cancer prognosis. Lung 200(3):347–379

CAS  Google Scholar 

Feng Y et al (2022) Genomic analysis reveals the prognostic and immunotherapeutic response characteristics of ferroptosis in lung squamous cell carcinoma. Lung 200(3):381–392

CAS  Google Scholar 

Lococo F et al (2022) Role of peripheral blood markers for detecting response and predicting prognosis in patients with non-small-cell lung cancer undergoing neoadjuvant therapy and surgery. Lung 200(3):393–400

CAS  Google Scholar 

Bertoglio P et al (2022) Impact of high-grade patterns in early-stage lung adenocarcinoma: a multicentric analysis. Lung 200(5):649–660

CAS  Google Scholar 

Shen F et al (2022) Prognostic value of geriatric nutritional risk index for patients with non-small cell lung cancer: a systematic review and meta-analysis. Lung 200(5):661–669

Google Scholar 

Avrillon V et al (2022) Nationwide real-life safety and treatment exposure data on durvalumab after concurrent chemoradiotherapy in unresectable stage III, locally advanced, non-small cell lung cancer: analysis of patients enrolled in the French Early Access Program. Lung 200(1):95–105

CAS  Google Scholar 

Doerr F et al (2022) Stage I and II small-cell lung cancer-new challenge for surgery. Lung 200(4):505–512

Google Scholar 

Zhu W, Tan C, Zhang J (2022) Alveolar epithelial type 2 cell dysfunction in idiopathic pulmonary fibrosis. Lung 200(5):539–547

Google Scholar 

Shao M et al (2022) Pathophysiological changes in rhesus monkeys with paraquat-induced pulmonary fibrosis. Lung 200(5):549–560

CAS  Google Scholar 

Todd JL et al (2022) Association of circulating proteins with death or lung transplant in patients with idiopathic pulmonary fibrosis in the IPF-PRO registry cohort. Lung 200(1):11–18

CAS  Google Scholar 

Kim HJ et al (2022) Clinical outcomes of patients with combined idiopathic pulmonary fibrosis and emphysema in the IPF-PRO registry. Lung 200(1):21–29

CAS  Google Scholar 

Yang S et al (2022) Serum oncomarkers in patients with MPO-ANCA-positive vasculitis: diagnostic and prognostic predictive values for interstitial lung disease. Lung 200(3):331–338

CAS  Google Scholar 

Park H et al (2022) Child interstitial lung disease in an infant with surfactant protein C dysfunction due to c. 202G>T variant (p. V68F). Lung 200(1):67–71

CAS  Google Scholar 

RoyChoudhury A et al (2022) Survival by lung-transplantation preference in interstitial lung disease patients with severe pulmonary hypertension and high lung allocation score (correspondence). Lung 200(1):137–139

Google Scholar 

Kalra SS et al (2022) Hypersensitivity pneumonitis with and without autoimmune features: a clinical comparative analysis. Lung 200(6):763–771

CAS  Google Scholar 

Lim HF et al (2022) Shortened telomere length in sputum cells of bronchiectasis patients is associated with dysfunctional inflammatory pathways. Lung 200(3):401–407

CAS  Google Scholar 

Araujo AS et al (2022) Effects of pulmonary rehabilitation on systemic inflammation and exercise capacity in bronchiectasis: a randomized controlled trial. Lung 200(3):409–417

Google Scholar 

McGarvey LP, Birring SS, Morice AH et al (2022) Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials. Lancet 399(10328):909–923. https://doi.org/10.1016/S0140-6736(21)02348-5

Article  Google Scholar 

Dicpinigaitis PV (2021) Coming soon: the first-ever drug(s) for refractory chronic cough (editorial). Lung 199(2):83–84

Google Scholar 

Chung KF et al (2022) Tackling the neuropathic cough of idiopathic pulmonary fibrosis (IPF): more needs to be done. Lung 200(6):673–675

Google Scholar 

Kaulamo JT, Latti AM, Koskela HO (2022) Cough in the elderly during the COVID-19 pandemic. Lung 200(2):161–168

CAS  Google Scholar 

Rudd M, Song W-J, Small PM (2022) The statistics of counting coughs: easy as 1,2,3? (editorial). Lung 200(5):531–537

Google Scholar 

Schelfhout J et al (2022) Validation and meaningful change thresholds for an objective cough frequency measurement in chronic cough. Lung 200(6):717–724

Google Scholar 

An J et al (2022) Cough presentation and cough-related healthcare utilization in tertiary care: analysis of routinely collected academic institutional database. Lung 200(4):431–439

Google Scholar 

Song W-J, Yu C-J, Kang SH (2022) Cough characteristics and healthcare journeys of chronic cough patients in community-based populations in South Korea and Taiwan. Lung 200(6):725–736

Google Scholar 

Kaneko H, Suzuki A, Horie J (2022) Effects of cough training and inspiratory muscle training on cough strength in older adults: a randomized controlled trial. Lung 200(1):49–57

Google Scholar 

Nussbaum J et al (2022) A randomized, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of 3 weeks of orally administered gefapixant in healthy younger and older adults. Lung 200(3):315–323

CAS  Google Scholar 

Smith JA et al (2022) Improvements in objective and subjective measures of chronic cough with gefapixant: a pooled phase 3 efficacy analysis of predefined subgroups. Lung 200(4):423–429

CAS